In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002)

Clinical Cancer Research

Volumn 6, Issue 3, 2000, Pages 880-886

  Hu, Limin ^a   Zaloudek, Charles ^b   Mills, Gordon B ^c   Gray, Joe ^b   Jaffe, Robert B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ENZYME INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHROPOMETRY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASCITES; BODY WEIGHT; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; ENZYME INHIBITION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; ASCITES; CELL DIVISION; CHROMONES; ENZYME INHIBITORS; FEMALE; HUMANS; MICE; MICE, NUDE; MORPHOLINES; NEOPLASMS, EXPERIMENTAL; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0034100051     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Perez, R. P., Godwin, A. K., Hamilton, T. C., and Ozols, R. F. Ovarian cancer biology. Semin. Oncol., 18: 186-204, 1991.
2. Dunton, C. J. New options for the treatment of advanced ovarian cancer. Semin Oncol., 24 (Suppl. 5): 2-11, 1997.
3. Shayesteh, L., Lu Y., Kuo, W. L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, C. B., Mills, G. B., and Gray, J. W. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet., 21: 99-102, 1999.
4. Cantley, L. C., Auger, K. R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R., and Soltoff, S. Oncogenes and signal transduction. Cell, 64: 281-302, 1991.
5. Carpenter, C. L., Duckworth, B. C., Auger, K. R., Cohen, B., Schaffhausen, B. S., and Cantley, L. C. Purification and characterization of phosphoinositide 3-kinase from rat liver. J. Biol. Chem., 265: 19704-19711, 1990.
6. Carpenter, C. L., and Cantley, L. C. Phosphoinositide kinases. Biochemistry, 29: 11147-11156, 1990.
7. Varticovski, L., Harrison-Findik, D., Keeler, M. L., and Susa, M. Role of PI3-kinase in mitogenesis. Biochim. Biophys. Acta, 1226: 1-11, 1994.
8. Hu, Q., Klippel, A., Muslin, A. J., Fantl, W. J., and Williams, L. T. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science (Washington DC), 268: 100-102, 1995.
9. Pignataro, O. P., and Ascoli, M. Epidermal growth factor increases the labeling of phosphatidylinositol 3,4-bisphosphate in MA-10 Leydig tumor cells. J. Biol. Chem., 265: 1718-1723, 1990.
10. Grasso, A. W., Wen, D., Miller, C. M., Rhim, J. S., Pretlow, T. G., and Kung, H. J. ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene, 15: 2705-2716, 1997.
11. Gliozzo, B., Sung, C. K., Scalia, P., Papa, V., Frasca, F., Sciacca, L., Giorgino, F., Milazzo, G. Insulin-stimulated cell growth in insulin receptor substrate-1-deficient ZR-75-1 cells is mediated by a phosphatidylinositol-3-kinase-independent pathway. J. Cell. Biochem., 70: 268-280, 1998.
12. Mesiano, S., Ferrara, N., and Jaffe, R. B. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. Am. J. Pathol., 153: 1249-1256, 1998.
13. Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem., 269: 5241-5248, 1994.
14. 1 CDKs in choroidal melanoma cells. FEBS Lett., 422: 385-390, 1998.
15. Thomas, J. E., Venugopalan, M., Galvin, R., Wang, Y., Bokoch, G. M., and Vlahos, C. J. Inhibition of MG-63 cell proliferation and PDGF-stimulated cellular processes by inhibitors of phosphatidylinositol 3-kinase. J. Cell. Biochem., 64: 182-195, 1997.
16. Roche, S., Downward, J., Raynal, P., and Courtneidge, S. A. A function for phosphatidylinositol 3-kinase β (p85α-p110β) in fibroblasts during mitogenesis: requirement for insulin- and lysophosphatidic acid-mediated signal transduction. Mol. Cell. Biol., 18: 7119-7129, 1998.
17. Kulik, G., Klippel, A., and Weber, M. J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and AKT. Mol. Cell. Biol., 17: 1595-1606, 1997., 1997.
18. Pellegatta, F., Chierchia, S. L., and Zocchi, M. R. Functional association of platelet endothelial cell adhesion molecule-1 and phosphoinositide 3-kinase in human neutrophils. J. Biol. Chem., 273: 27768-27777, 1998.
19. Kanda, S., Hodgkin, M. N., Woodfield, R. J., Wakelam, M. J., Thomas, G., and Claesson-Welsh. L. Phosphatidylinositol 3′-kinase-independent p70 S6 kinase activation by fibroblast growth factor receptor-1 is important for proliferation but not differentiation of endothelial cells. J. Biol. Chem., 272: 23347-23353, 1997.
20. Dufourny, B., Alblas, J., van Teeffelen, H. A., van Schaik, F. M., van der Burg, B., Steenbergh, P. H., Sussenbach, J. S. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J. Biol. Chem., 272: 31163-31171, 1997.
21. Downward, J. Ras signaling and apoptosis. Curr. Opin. Genet. Dev., 1: 49-54, 1998.
22. Sandoval, D., Gukovskaya, A., Reavey, P., Gukovsky, S., Sisk, A., Braquet, P., Pandol, S. J., Poucell-Hatton, S. The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. Gastroenterology, 4: 1081-1091, 1996.
23. Gerber, H. P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V., Ferrara, N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem., 273: 30336-30343, 1998.
24. Senger, D. R., Van de Water, L., Brown, L. F., Nagy, J. A., Yeo, K. T., Yeo, T. K., Berse, B., Jackman, R. W., Dvorak, A. M., Dvorak, H. F. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev., 12: 303-324, 1993.
25. Pham, C. D., Roberts, T. P., van Bruggen, N., Melnyk, O., Mann, J., Ferrara, N., Cohen, R. L., Brasch, R. C. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest., 16: 225-230, 1998.
26. D'Armiento, J., DiColandrea, T., Dalal, S. S., Okada, Y., Huang, M. T., Conney, A. H., Chada, K. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol. Cell. Biol., 10: 5732-5739, 1995.
27. Ishida-Yamamoto, A., Takahashi, H., Presland, R. B., Dale, B. A., and Lizuka, H. Translocation of profilaggrin N-terminal domain into keratinocyte nuclei with fragmented DNA in normal human skin and loricrin keratoderma. Lab. Invest., 10: 1245-1253, 1998.